Key Highlights

  • Cardinal Health's $0.5158 quarterly dividend goes ex-dividend October 1, 2026 and is payable October 15 to shareholders of record.
  • Fiscal 2026 revenue was $254.2 billion, with GAAP diluted EPS of $7.23 and non-GAAP diluted EPS of $11.26.
  • Fourth-quarter GAAP diluted EPS was $1.70, and non-GAAP diluted EPS was $2.91, including a $0.31 one-time tariff refund benefit.
  • Fiscal 2027 non-GAAP EPS guidance is $12.40 to $12.60, and the board approved a $5.0 billion incremental repurchase authorization.

Overview

Cardinal Health, Inc.'s (NYSE:CAH) $0.5158 quarterly dividend yields 0.91% and is an increase from $0.5107, approved May 5, 2026. Fiscal 2026 GAAP diluted EPS was $7.23 and non-GAAP diluted EPS was $11.26, and common dividends paid during the year were $2.04 per share. Cardinal also repurchased $1.4 billion of its stock during fiscal 2026.

Dividend Program and Shareholder Returns

Cardinal Health's board approved a quarterly dividend of $0.5158 per share on May 5, 2026, an increase from $0.5107. It was paid July 15, and the same $0.5158 amount is payable October 15, 2026 to shareholders of record on October 1.

Common dividends paid during fiscal 2026 totaled $2.04 per share. The company identifies no separate supplemental common dividend, and dividend decisions remain subject to board approval and financial conditions.

About the Company

Cardinal Health is a healthcare services and products company operating across pharmaceutical and specialty distribution, medical products and related services. It distributes pharmaceuticals to pharmacies, hospitals and healthcare providers and supplies medical products to hospitals and ambulatory facilities.

Financial Performance Behind the Payout

Cardinal reported fiscal fourth-quarter revenue of $63.7 billion, up 6%. GAAP operating earnings rose 70% to $729 million and GAAP diluted EPS rose 70% to $1.70. Non-GAAP operating earnings rose 30% to $935 million, and non-GAAP diluted EPS rose 40% to $2.91.

Fiscal 2026 revenue was $254.2 billion, up 14%. GAAP operating earnings were $2.6 billion and GAAP diluted EPS was $7.23. Non-GAAP operating earnings rose 30% to $3.6 billion, and non-GAAP diluted EPS rose 37% to $11.26.

Fiscal year operating cash flow was $5.2 billion and adjusted free cash flow was $5.0 billion.

A One-Time Tariff Refund Reported Separately From Core Earnings

The fourth-quarter non-GAAP result includes a one-time net operating profit impact of $100 million from the recognition of IEEPA tariff refunds in the GMPD segment, which the company states added $0.31 to non-GAAP diluted EPS. Excluding it, fourth-quarter non-GAAP diluted EPS rose 25% to $2.60 and fiscal year non-GAAP diluted EPS rose 33% to $10.95.

Cardinal completed an incremental $350 million share repurchase, bringing the fiscal 2026 repurchase total to $1.4 billion, and its board approved a $5.0 billion incremental repurchase authorization.

Outlook

Cardinal Health's fiscal 2027 non-GAAP EPS guidance is $12.40 to $12.60, which the company describes as 13% to 15% growth, and its board approved a $5.0 billion incremental repurchase authorization. The IEEPA tariff refund is reported separately in GAAP and non-GAAP results.